Overview: Amylase Fluid TestIntroduction: The Amylase Fluid Test measures amylase in body fluids to diagnose conditions like pancreatic leaks or infections causing abdominal pain or swelling. Following 2023 AGA guidelines, it uses spectrophotometry for high accuracy, aiding in metabolic screening. This test is critical for guiding treatment, monitoring complications, and improving outcomes in biochemistry and clinical pathology.
Other Names: Fluid Amylase Assay, Pancreatic Fluid Amylase Test.
FDA Status: Laboratory-developed test (LDT), meeting biochemistry standards for diagnostic accuracy.
Historical Milestone: Amylase testing began in the 1950s with serum assays. Fluid amylase tests emerged in the 1980s, and by the 2000s, spectrophotometric methods improved precision for fluid analysis.
Purpose: Diagnoses pancreatic leaks or infections, guides treatment, and monitors complications in patients with abdominal pain or swelling.
Test Parameters: 1. Amylase
Pretest Condition: Fasting for 10-12 hours required to stabilize enzyme levels. Collect body fluid after overnight fasting. Report symptoms like abdominal pain or swelling, and list medications like painkillers.
Specimen: 5-10 mL body fluid, pleural fluid, or peritoneal fluid (sterile container). Transport in a biohazard bag within 24 hours.
Sample Stability at Room Temperature: 24 hours
Sample Stability at Refrigeration: 48 hours
Sample Stability at Frozen: Not frozen
Medical History: Document pancreatic symptoms, recent surgery, or family history of pancreatic disorders. Include current medications, especially those affecting pancreatic function.
Consent: Written consent required, detailing the tests purpose, diagnostic implications, and potential need for imaging or surgery.
Procedural Considerations: Uses spectrophotometry to measure amylase in body fluids. Results are available in 1-2 days, enabling rapid clinical decisions.
Factors Affecting Result Accuracy: Contaminated fluid samples or recent surgery may alter results. Improper storage can degrade samples.
Clinical Significance: Elevated amylase levels suggest pancreatic leaks or infections, prompting surgical or medical intervention. Normal levels may require further imaging.
Specialist Consultation: Consult a gastroenterologist or surgeon for result interpretation. A pancreatic specialist referral is advised for confirmed cases.
Additional Supporting Tests: Serum amylase test, lipase test, or abdominal imaging to confirm pancreatic leaks or infections.
Test Limitations: False positives may occur with salivary contamination or other fluid sources. Results require clinical correlation.
References: AGA Pancreatitis Guidelines, 2023; Gastroenterology, Whitcomb DC, 2022.
